X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7980) 7980
Book Review (3340) 3340
Publication (513) 513
Book / eBook (143) 143
Newsletter (119) 119
Book Chapter (44) 44
Conference Proceeding (25) 25
Newspaper Article (15) 15
Magazine Article (8) 8
Transcript (6) 6
Dissertation (3) 3
Presentation (2) 2
Data Set (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7358) 7358
humans (7343) 7343
oncology (3286) 3286
female (3236) 3236
male (2959) 2959
cancer (2890) 2890
antineoplastic agents - therapeutic use (2638) 2638
middle aged (2389) 2389
chemotherapy (2116) 2116
aged (1977) 1977
adult (1844) 1844
antineoplastic agents - adverse effects (1840) 1840
animals (1812) 1812
treatment outcome (1619) 1619
care and treatment (1515) 1515
immunotherapy (1506) 1506
antineoplastic agents (1332) 1332
antineoplastic combined chemotherapy protocols - therapeutic use (1260) 1260
hematology (1127) 1127
pharmacology & pharmacy (1077) 1077
antimitotic agents (1069) 1069
therapy (1020) 1020
antineoplastic agents - administration & dosage (948) 948
neoplasms - drug therapy (932) 932
research (922) 922
medicine & public health (898) 898
antineoplastic agents - pharmacology (892) 892
health aspects (875) 875
drug therapy (861) 861
immunology (808) 808
antibodies, monoclonal - therapeutic use (771) 771
analysis (732) 732
tumors (729) 729
combined modality therapy (706) 706
prognosis (691) 691
melanoma (677) 677
aged, 80 and over (676) 676
antineoplastic combined chemotherapy protocols - adverse effects (654) 654
metastasis (640) 640
mice (637) 637
clinical trials as topic (611) 611
antineoplastic agents, immunological - adverse effects (598) 598
antineoplastic agents, immunological - therapeutic use (582) 582
clinical trials (563) 563
risk factors (541) 541
survival (541) 541
immunologic factors - therapeutic use (535) 535
hematology, oncology and palliative medicine (512) 512
rituximab (485) 485
abridged index medicus (483) 483
apoptosis (480) 480
melanoma - drug therapy (478) 478
retrospective studies (472) 472
immunotherapy - methods (470) 470
adolescent (465) 465
cancer therapies (452) 452
disease-free survival (444) 444
medical research (435) 435
patients (430) 430
antibodies, monoclonal - adverse effects (420) 420
child (420) 420
transplantation (420) 420
neoplasm staging (413) 413
toxicity (411) 411
neoplasms - immunology (405) 405
monoclonal antibodies (398) 398
cell line, tumor (397) 397
ipilimumab (395) 395
lung neoplasms - drug therapy (377) 377
survival analysis (377) 377
medicine, research & experimental (372) 372
article (371) 371
skin neoplasms - drug therapy (371) 371
phase-ii trial (366) 366
neoplasms - therapy (363) 363
molecular targeted therapy (361) 361
breast cancer (356) 356
open-label (353) 353
dose-response relationship, drug (347) 347
breast neoplasms - drug therapy (345) 345
leukemia (345) 345
t cells (343) 343
expression (337) 337
surgery (337) 337
time factors (335) 335
nivolumab (334) 334
trial (334) 334
young adult (330) 330
development and progression (329) 329
survival rate (328) 328
internal medicine (314) 314
metastatic melanoma (314) 314
cells (313) 313
cancer research (312) 312
dermatology (310) 310
cytotoxicity (307) 307
antineoplastic combined chemotherapy protocols - administration & dosage (306) 306
medicine (303) 303
dosage and administration (302) 302
phase-ii (302) 302
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (107) 107
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Chemistry (A D Allen) - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Online Resources - Online (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Reference (1) 1
Gerstein Science - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8133) 8133
French (36) 36
German (35) 35
Spanish (14) 14
Japanese (12) 12
Russian (12) 12
Danish (9) 9
Italian (8) 8
Hungarian (7) 7
Polish (5) 5
Dutch (2) 2
Serbian (2) 2
Chinese (1) 1
Croatian (1) 1
Finnish (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
Annals of Oncology, ISSN 0923-7534, 2017, Volume 28, Issue 2, pp. 368 - 376
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Summary Background Clinical trials have shown that trastuzumab, a recombinant monoclonal antibody against HER2 receptor, significantly improves overall... 
Internal Medicine | SYSTEM | MEDICINE, GENERAL & INTERNAL | MULTICENTER | PHASE-3 TRIAL | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | PERTUZUMAB | Antineoplastic Agents, Immunological - administration & dosage | Trastuzumab - therapeutic use | Drug Administration Schedule | Follow-Up Studies | Biomarkers, Tumor - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Trastuzumab - adverse effects | Treatment Outcome | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Antineoplastic Agents, Immunological - adverse effects | Breast Neoplasms - chemistry | Antineoplastic Agents, Immunological - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Adult | Female | Aged | Receptor, ErbB-2 - analysis | Heart Diseases - chemically induced | Antimitotic agents | Medical colleges | Analysis | Adjuvant treatment | Monoclonal antibodies | Breast cancer | Antineoplastic agents | Cancer | Heart | Laboratories | Toxicity | Medical services | Clinical trials | Cancer therapies | Incidence | Motivation | Failure analysis | Surgery | Heart diseases | Recombinant | Medical research | Health risks | Mammography | Radiation therapy | Patients | Survival | ErbB-2 protein | Chemotherapy | Breast | Informed consent | Trastuzumab | Schedules | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10105, pp. 1853 - 1862
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2016, Volume 34, Issue 32, pp. 3838 - 3845
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 405 - 415
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1480 - 1492
Journal Article